125 related articles for article (PubMed ID: 7173627)
1. Noncontact detection of ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine: first clinical results.
Bockslaff H; Kloster G; Dausch D; Schad K; Hundeshagen H
Graefes Arch Clin Exp Ophthalmol; 1982; 219(3):149-54. PubMed ID: 7173627
[TBL] [Abstract][Full Text] [Related]
2. Noncontact detection of experimental amelanotic ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine.
Bockslaff H; Spitznas M; Hahn I; Kloster G
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 217(4):255-66. PubMed ID: 6915722
[TBL] [Abstract][Full Text] [Related]
3. [Noncontact detection of intraocular lesions by means of a gamma scintillation camera].
Bockslaff H; Dausch D; Bornemann H; Stöppler L; Hundeshagen H
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Sep; 211(3):187-203. PubMed ID: 316287
[TBL] [Abstract][Full Text] [Related]
4. [123I-alpha-methyltyrosine scintigraphy in malignant melanoma].
Steinert H; Böni R; Huch-Böni RA; Capaul R; von Schulthess GK; Westera G
Nuklearmedizin; 1997 Mar; 36(2):36-41. PubMed ID: 9148271
[TBL] [Abstract][Full Text] [Related]
5. Visualization of ocular melanoma with N-isopropyl-p-[123I]-iodoamphetamine.
Ono S; Fukunaga M; Otsuka N; Nagai K; Morita K; Furukawa T; Muranaka A; Yanagimoto S; Tomomitsu T; Tabuchi A
J Nucl Med; 1988 Aug; 29(8):1448-50. PubMed ID: 3404259
[TBL] [Abstract][Full Text] [Related]
6. L-3-123I-alpha-methyltyrosine for melanoma detection: a comparative evaluation.
Kloster G; Bockslaff H
Int J Nucl Med Biol; 1982; 9(4):259-69. PubMed ID: 6225742
[TBL] [Abstract][Full Text] [Related]
7. Uptake of 123I-5-iodo-2-thiouracil, a possible radiopharmaceutical for noninvasive detection of ocular melanoma, in melanotic and amelanotic melanomas in hamsters.
Franken NA; Van Langevelde A; Journée-De Korver JG; Bakker CN; Feitsma RI; Van Delft JL; Oosterhuis JA; Pauwels EK
Nucl Med Commun; 1985 Oct; 6(10):657-63. PubMed ID: 4088550
[TBL] [Abstract][Full Text] [Related]
8. Detection of ocular melanoma with 4-(3-dimethylaminopropylamino)-7-[123I]-iodoquinoline.
Lambrecht RM; Packer S; Wolf AP; Lloyd D; Atkins HL
J Nucl Med; 1984 Jul; 25(7):800-4. PubMed ID: 6737079
[TBL] [Abstract][Full Text] [Related]
9. L-3-[123I]Iodo-alpha-methyltyrosine scintigraphy in carcinoid tumors: correlation with biochemical activity and comparison with [111In-DTPA-D-Phe1]-octreotide imaging.
Jager PL; Meijer WG; Kema IP; Willemse PH; Piers DA; de Vries EG
J Nucl Med; 2000 Nov; 41(11):1793-800. PubMed ID: 11079485
[TBL] [Abstract][Full Text] [Related]
10. Scintimetric detection of choroidal malignant melanoma with [123I]-5-iodo-2-thiouracil.
Franken NA; van Delft JL; van Langevelde A; Bleeker JC; de Wolff-Rouendaal D; van Best JA; Bouwhuis-Hoogerwerf ML; Oosterhuis JA; Pauwels EK
Ophthalmologica; 1986; 193(4):248-54. PubMed ID: 3587880
[TBL] [Abstract][Full Text] [Related]
11. [Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].
Sillaire-Houtmann I; Bonafous J; Veyre A; Mestas D; D'Incan M; Moins N; Kemeny JL; Chossat F; Bacin F
J Fr Ophtalmol; 2004 Jan; 27(1):34-9. PubMed ID: 14968075
[TBL] [Abstract][Full Text] [Related]
12. Potential radiopharmaceuticals for the detection of ocular melanoma. Part II. Iodoquinoline derivatives and 67Ga-citrate.
van Langevelde A; Bakker CN; Boer H; Ilmer TA; Journée-de Korver JA; Kaspersen FM; Noach EL; Oosterhuis JA; Pauwels EK
Eur J Nucl Med; 1986; 12(2):96-104. PubMed ID: 3460807
[TBL] [Abstract][Full Text] [Related]
13. Melanoma affine radiopharmaceuticals I. A comparative study of 131I-labeled quinoline and tyrosine derivatives.
Bubeck B; Eisenhut M; Heimke U; zum Winkel K
Eur J Nucl Med; 1981; 6(5):227-33. PubMed ID: 6788553
[TBL] [Abstract][Full Text] [Related]
14. Limited sensitivity of iodine-123-2-hydroxy-3-iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl ] benzamide whole-body scintigraphy in patients with malignant melanoma: a comparison with thallium-201 imaging.
Brenner W; Klomp HJ; Bohuslavizki KH; Szonn B; Kampen WU; Henze E
Eur J Nucl Med; 1999 Dec; 26(12):1567-71. PubMed ID: 10638408
[TBL] [Abstract][Full Text] [Related]
15. 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET.
Langen KJ; Ziemons K; Kiwit JC; Herzog H; Kuwert T; Bock WJ; Stöcklin G; Feinendegen LE; Müller-Gärtner HW
J Nucl Med; 1997 Apr; 38(4):517-22. PubMed ID: 9098193
[TBL] [Abstract][Full Text] [Related]
16. Tumor detection with radiopharmaceuticals.
Packer S
Semin Nucl Med; 1984 Jan; 14(1):21-30. PubMed ID: 6369546
[TBL] [Abstract][Full Text] [Related]
17. Potential radiopharmaceuticals for the detection of ocular melanoma. Part I. 5-iodo-2-thiouracil derivatives.
van Langevelde A; Bakker CN; Broxterman HJ; Journée-de Korver JG; Kaspersen FM; Oosterhuis JA; Pauwels EK
Eur J Nucl Med; 1983; 8(2):45-51. PubMed ID: 6840126
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine-labelled alpha-methyl-tyrosine in malignant melanoma: cell culture studies and results in patients.
Böni R; Steinert H; Huch Böni R; Von Schulthess GK; Meyer J; Dummer R; Burg G; Westera G
Br J Dermatol; 1997 Jul; 137(1):96-100. PubMed ID: 9274632
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-alpha-methyltyrosine SPET.
Dierickx LO; Lahoutte T; Deron P; Caveliers V; Vanhove C; Everaert H; Bossuyt A
Eur J Nucl Med; 2001 Mar; 28(3):282-7. PubMed ID: 11315594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
